Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa.
OBJECTIVES:Cryptococcal meningitis (CM)-related mortality may be prevented by screening patients for sub-clinical cryptococcal antigenaemia (CRAG) at antiretroviral-therapy (ART) initiation and pre-emptively treating those testing positive. Prior to programmatic implementation in South Africa we per...
Main Authors: | Joseph N Jarvis, Thomas S Harrison, Stephen D Lawn, Graeme Meintjes, Robin Wood, Susan Cleary |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3716603?pdf=render |
Similar Items
-
Immune correlates of HIV-associated cryptococcal meningitis.
by: Mark W Tenforde, et al.
Published: (2017-03-01) -
Paradoxical respiratory failure due to cryptococcal pneumonia after amphotericin B treatment for HIV-associated cryptococcal meningitis
by: James E. Scriven, et al.
Published: (2018-03-01) -
Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana [version 1; peer review: 2 approved]
by: Mark W. Tenforde, et al.
Published: (2019-09-01) -
Cost-effectiveness of reflex laboratory-based cryptococcal antigen screening for the prevention and treatment of cryptococcal meningitis in Botswana [version 2; peer review: 2 approved]
by: Mark W. Tenforde, et al.
Published: (2020-03-01) -
Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern Africa.
by: Mathew A Beale, et al.
Published: (2015-01-01)